ArticleScientific reports2026
A multimodal multi-scale transformer for virtual pretreatment patient-specific QA of SBRT using portal-dosimetry fluence maps.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
We developed a transformer-based multimodal neural network to predict the gamma passing rate (GPR) in stereotactic body radiation therapy (SBRT) patient-specific quality assurance. Using 1265 SBRT beams from two institutions, the model incorporated portal dose prediction fluence maps with beam complexity descriptors such as modulation complexity score and monitor units. A multi-scale visual-textual transformer, integrating a ViT encoder and feedforward network through a fusion head, was compared with state-of-the-art CNNs across nine gamma criteria. Our approach consistently achieved the lowest root mean squared error (RMSE) and mean absolute error (MAE), with values ranging from 0.785% to 4.258% and 0.418% to 3.197%, respectively, and ablation studies highlighted the necessity of multimodal fusion and multi-scale design. These results demonstrate superior predictive accuracy and generalizability, underscoring the potential of transformer-based multimodal learning to enhance treatment optimization and clinical QA efficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.